New and revised data caputre forms are released on a monthly basis. See below for a list of the most current new and revised forms.
Full details regarding the revisions (e.g. new questions, modified questions, removed questions) are located on the CIBMTR Portal {Training & eLearning > Release Education}
For questions about the forms or revision schedule, submit a ticket via CIBMTR Center Support > Form Revision.
*Next Release: February 20th, 2026
January 23rd, 2026
| Forms |
Notes |
| F2005 r5 Recipient Eligibility |
|
| F2548 r1 Exagamglogene autotemcel (Casgevy®) Pre-Infusion Supplemental Data |
Study Specific Form |
| F2549 r1 Exagamglogene autotemcel (Casgevy®) Post-Infusion Supplemental Data |
Study Specific Form |
| F4000 r11 Pre-Cellular Therapy Essential Data |
|
| F4001 r2 Pre-Cellular Therapy Baseline Data |
|
| F4003 r6 Cellular Therapy Product |
|
| F4006 r7 Cellular Therapy Infusion |
|
| F4101 r2 Post-Cellular Therapy Follow-Up |
|
!Due to unforeseen circumstances, the release of Form 4100 r10, previously scheduled for January 23, 2026, will be delayed. The updated release date for this form is February 20, 2026. Additionally, the Grade 3 and Grade 4 organ toxicity questions within the Toxicity Section will remain in Form 4100 r10 and will not be removed. These questions will be restricted to study-enrolled CRIDs only.
December 12th, 2025
| Forms |
Notes |
| F2018 r7 Hodgkin and Non-Hodgkin Lymphoma (LYM) Pre-Infusion Data |
|
| F2026 r3 Neuroblastoma Pre-Infusion Data |
|
| F2126 r3 Neuroblastoma Post-Infusion Form |
|
October 24th, 2025
| Forms |
Notes |
| F2030 r5 Sickle Cell Pre-Infusion Data |
|
| F2130 r5 Sickle Cell Post-Infusion Data |
|
| F2199 r2 Donor Cellular Infusion |
Form name change |
| F2400 r11 Pre-Transplant Essential Data |
|
| F2402 r10 Disease Classification |
|
| F2004 r6 Infectious Disease Markers |
|
| F2005 r8 Confirmation of HLA Typing |
|
| F2006 r7 Hematopoietic Cellular Transplant (HCT) Infusion |
|
| F2450 r9 Post-Transplant Essential Data |
|
| F2900 r6 Recipient Death Data |
|
| F3500 r3 Subsequent Neoplasms |
|
| F2804 r7 CRID Assignment Tool |
|
| F2451 r3 Chimerism Essential Data |
Released for CRF Reporting in Summer 2025, will now be used for TED-Level Reporting as well |
| F2807 R1 Race, Ethnicity and Ancestry |
NEW form |
July 25th, 2025
| Forms |
Notes |
| F2451r3 Chimerism Essential Data |
|
April 18th, 2025
| Forms |
Notes |
| F3501r3 Pregnancy |
|
January 24th, 2025
| Forms |
Notes |
| F2059r1 Solid Tumor Pre-Infusion |
NEW Form |
| F2554r3 CMS Registration |
|
| F3507r1 Solid Tumor Response |
NEW Form |
October 25th, 2024
| Forms |
Notes |
| F2013r4 Chronic Lymphocytic Leukemia (CLL) Pre-Infusion Data |
|
| F2113r4 Chronic Lymphocytic Leukemia (CLL) Post-Infusion Data |
|
| F2030r4 Sickle Cell Disease Pre-Infusion Data |
|
| F2130r4 Sickle Cell Disease Post-Infusion Data |
|
| F2402r9 Pre-TED Disease Classification |
|
| F3502r1 Laboratory Studies |
NEW Form |
| F3505r1 Transfusion |
NEW Form |
| F3506r1 Marrow Surveillance |
NEW Form |
July 26th, 2024
| Forms |
Notes |
| F2814r5 Indication for CIBMTR Data Reporting |
|
| F2450r8 Post-Transplant Essential Data |
|
| F2003r2 Gene Therapy Product |
|
| F2037r4 Leukodystrophies Pre-Infusion |
|
| F2137r4 Leukodystrophies Post-Infusion |
|
| F2058r2 Thalassemia Pre-Infusion Data |
|
| F2158r2 Thalassemia Post-Infusion Data |
|
| F2545r1 Betibeglogene Autotemcel (Zynteglo) Pre-Infusion Supplemental Data |
NEW Form* |
| F2545r1 Betibeglogene Autotemcel (Zynteglo) Post-Infusion Supplemental Data |
NEW Form* |
| F2546r1 Elivaldogene Autotemcel (Skysona) Pre-Infusion Supplemental Data |
NEW Form* |
| F2547r1 Elivaldogene Autotemcel (Skysona) Post-Infusion Supplemental Data |
NEW Form* |
| F3503r1 Neurocognitive Assessment |
NEW Form* |
*Released September 27th, 2024
Last modified:
Jan 23, 2026